Literature DB >> 30632618

Natural killer cell transcriptional control, subsets, receptors and effector function.

Daniel M Altmann1.   

Abstract

There have been considerable advances in characterization of the complexities of natural killer (NK) cell ligand recognition, activation, subsets and effector functions. The nature of the transcription factors that act to define distinctive functional programmes of NK cell subsets are now starting to be clarified as a consequence of studies in knockouts. Importantly, this is being extended to improved understanding of the nature of NK cell memory. As NK cell biology offers increasing resonance with analogous pathways in CD8 biology, some have made the case that immunology may sometimes benefit from a little less conceptual 'splitting' and a little more conceptual 'lumping.'
© 2019 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30632618      PMCID: PMC6329198          DOI: 10.1111/imm.13041

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  8 in total

1.  New windows open for immunotherapy in lung cancer.

Authors:  Lizza Hendriks; Benjamin Besse
Journal:  Nature       Date:  2018-06       Impact factor: 49.962

Review 2.  Killer-cell immunoglobulin-like receptors on the cusp of modern immunogenetics.

Authors:  Francesco Colucci; James Traherne
Journal:  Immunology       Date:  2017-09-12       Impact factor: 7.397

Review 3.  Natural killer cell cytotoxicity and its regulation by inhibitory receptors.

Authors:  Santosh Kumar
Journal:  Immunology       Date:  2018-04-11       Impact factor: 7.397

Review 4.  Defining the role of NK cells during dengue virus infection.

Authors:  Anuja Mathew
Journal:  Immunology       Date:  2018-03-23       Impact factor: 7.397

5.  Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.

Authors:  Malcolm J W Sim; Stacy A Malaker; Ayesha Khan; Janet M Stowell; Jeffrey Shabanowitz; Mary E Peterson; Sumati Rajagopalan; Donald F Hunt; Daniel M Altmann; Eric O Long; Rosemary J Boyton
Journal:  Front Immunol       Date:  2017-03-14       Impact factor: 7.561

Review 6.  Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

Authors:  Pascale André; Caroline Denis; Caroline Soulas; Clarisse Bourbon-Caillet; Julie Lopez; Thomas Arnoux; Mathieu Bléry; Cécile Bonnafous; Laurent Gauthier; Ariane Morel; Benjamin Rossi; Romain Remark; Violette Breso; Elodie Bonnet; Guillaume Habif; Sophie Guia; Ana Ines Lalanne; Caroline Hoffmann; Olivier Lantz; Jérôme Fayette; Agnès Boyer-Chammard; Robert Zerbib; Pierre Dodion; Hormas Ghadially; Maria Jure-Kunkel; Yannis Morel; Ronald Herbst; Emilie Narni-Mancinelli; Roger B Cohen; Eric Vivier
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

7.  High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice.

Authors:  Adeline Crinier; Pierre Milpied; Bertrand Escalière; Christelle Piperoglou; Justine Galluso; Anaïs Balsamo; Lionel Spinelli; Inaki Cervera-Marzal; Mikaël Ebbo; Mathilde Girard-Madoux; Sébastien Jaeger; Emilie Bollon; Sami Hamed; Jean Hardwigsen; Sophie Ugolini; Frédéric Vély; Emilie Narni-Mancinelli; Eric Vivier
Journal:  Immunity       Date:  2018-11-06       Impact factor: 31.745

Review 8.  Innate-like CD8+ T-cells and NK cells: converging functions and phenotypes.

Authors:  Ayako Kurioka; Paul Klenerman; Christian B Willberg
Journal:  Immunology       Date:  2018-03-14       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.